Home > Financial Ratios > BETA DRUGS

BETA DRUGS
Core EBITDA Growth

    Back to All Ratios
BETA DRUGS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BETA DRUGS
Please provide your vote to see the results

BETA DRUGS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 32.0813.8723.9972.1437.81

What is the latest Core EBITDA Growth ratio of BETA DRUGS ?

The latest Core EBITDA Growth ratio of BETA DRUGS is 32.08 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202532.08
Mar202413.87
Mar202323.99
Mar202272.14
Mar202137.81

How is Core EBITDA Growth of BETA DRUGS Trending?

Years Core EBITDA Growth % Change
Mar2025 32.08
131.29
Mar2024 13.87
-42.18
Mar2023 23.99
-66.75
Mar2022 72.14
90.80
Mar2021 37.81 -

Other Financial Ratios of BETA DRUGS


Compare Core EBITDA Growth ratio of peers of BETA DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BETA DRUGS ₹2,281.3 Cr -3% -14.3% 14.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,398.0 Cr -0.4% -3.3% 15.5% Stock Analytics
DIVIS LABORATORIES ₹248,664.0 Cr 0.4% 9.9% 55.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹182,738.0 Cr -3.4% -4.2% 37.1% Stock Analytics
CIPLA ₹110,794.0 Cr 0.5% -3.2% -12.8% Stock Analytics
DR REDDYS LABORATORIES ₹97,749.4 Cr 0.9% 0% -11% Stock Analytics


BETA DRUGS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BETA DRUGS

-3%

-14.3%

14.1%

SENSEX

-0.8%

-3.8%

-8.9%


You may also like the below Video Courses